Vanguard Personalized Indexing Management
PLRX icon

Vanguard Personalized Indexing Management’s Pliant Therapeutics PLRX Stock Holding History

Vanguard Personalized Indexing Management’s Portfolio PLRX Stock Details PLRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-10,029
Closed -$12.6K – 2317
2026
Q1 		$12.6K Sell
10,029
-16,208
-62% -$20.5K ﹤0.01% 2146
2025
Q4 		$32K Sell
26,237
-8,506
-24% -$12.8K ﹤0.01% 1919
2025
Q3 		$51.4K Sell
34,743
-797
-2% -$1.22K ﹤0.01% 1899
2025
Q2 		$41.2K Buy
35,540
+19,320
+119% +$27.3K ﹤0.01% 1851
2025
Q1 		$21.9K Buy
+16,220
New +$98.5K ﹤0.01% 1763

Other funds holding PLRX

TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $2.19B AUM 374.99% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
MAM
Monaco Asset Management Monaco $1.26B AUM 60.23% 1-Year Est. Return
LCM
Lynx1 Capital Management San Juan, Puerto Rico $866M AUM 231.68% 1-Year Est. Return
BCM
BML Capital Management Zionsville, Indiana $176M AUM 123.21% 1-Year Est. Return

Vanguard Personalized Indexing Management's PLRX Position: Q2 2026 in Review

Vanguard Personalized Indexing Management sold out of Pliant Therapeutics (PLRX) in Q2 2026, closing a stake of 10,029 shares — an estimated $12.6K sold.

Vanguard Personalized Indexing Management first reported a position in PLRX in Q1 2025 and held it in 5 quarters. The position peaked at $51.4K in Q3 2025. 86 funds tracked by Wall St. Rank hold PLRX as of Q2 2026.

  • Vanguard Personalized Indexing Management reported no remaining Pliant Therapeutics position as of Q2 2026 after selling out during the quarter.
  • Vanguard Personalized Indexing Management sold 10,029 Pliant Therapeutics shares in Q2 2026, an estimated $12.6K.
  • Vanguard Personalized Indexing Management first reported a position in Pliant Therapeutics in Q1 2025 and held it in 5 quarters.
  • Vanguard Personalized Indexing Management's Pliant Therapeutics position peaked at $51.4K in Q3 2025.
  • 86 funds tracked by Wall St. Rank held Pliant Therapeutics as of Q2 2026.

Based on Vanguard Personalized Indexing Management's 13F filing for Q2 2026, filed 11 Aug 2026.